- Home
- PWM vs TXMD Comparison
PWM vs TXMD Comparison
Compare PWM & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PWM
- TXMD
- Stock Information
- Founded
- PWM 2018
- TXMD 2008
- Country
- PWM Hong Kong
- TXMD United States
- Employees
- PWM N/A
- TXMD N/A
- Industry
- PWM
- TXMD Biotechnology: Pharmaceutical Preparations
- Sector
- PWM
- TXMD Health Care
- Exchange
- PWM Nasdaq
- TXMD Nasdaq
- Market Cap
- PWM 12.4M
- TXMD 12.7M
- IPO Year
- PWM 2023
- TXMD N/A
- Fundamental
- Price
- PWM $0.53
- TXMD $1.07
- Analyst Decision
- PWM
- TXMD
- Analyst Count
- PWM 0
- TXMD 0
- Target Price
- PWM N/A
- TXMD N/A
- AVG Volume (30 Days)
- PWM 1.2M
- TXMD 16.9K
- Earning Date
- PWM 02-13-2026
- TXMD 11-11-2025
- Dividend Yield
- PWM N/A
- TXMD N/A
- EPS Growth
- PWM N/A
- TXMD N/A
- EPS
- PWM N/A
- TXMD N/A
- Revenue
- PWM $639,912.00
- TXMD $2,559,000.00
- Revenue This Year
- PWM N/A
- TXMD $427.09
- Revenue Next Year
- PWM N/A
- TXMD N/A
- P/E Ratio
- PWM N/A
- TXMD N/A
- Revenue Growth
- PWM 83.60
- TXMD 156.93
- 52 Week Low
- PWM $0.31
- TXMD $0.70
- 52 Week High
- PWM $2.70
- TXMD $2.44
- Technical
- Relative Strength Index (RSI)
- PWM 54.53
- TXMD 42.49
- Support Level
- PWM $0.51
- TXMD $1.06
- Resistance Level
- PWM $0.58
- TXMD $1.14
- Average True Range (ATR)
- PWM 0.05
- TXMD 0.05
- MACD
- PWM -0.01
- TXMD 0.00
- Stochastic Oscillator
- PWM 24.34
- TXMD 11.05
About PWM Prestige Wealth Inc.
Prestige Wealth Inc is engaged in providing private wealth management services and asset management to high-net-worth and ultra-high-net-worth individuals and enterprises through its subsidiaries.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.